Shekhawat Chairs Medical Value Travel Stakeholder Meet
Synopsis
Key Takeaways
Union Culture and Tourism Minister Gajendra Singh Shekhawat on Wednesday, 22 July 2026 chaired a stakeholder interaction bringing together leading hospitals, AYUSH institutions, and representatives from key central ministries and departments to advance India's Medical Value Travel agenda. The meeting centred on concrete steps to sharpen India's global competitiveness in attracting international patients seeking affordable, high-quality healthcare and wellness services.
Context
Shekhawat described the session as a 'productive interaction' covering three priority areas: streamlined visa processes, improved insurance and payment mechanisms, and stronger global promotion of India's healthcare and wellness ecosystem. Tagging the Prime Minister's Office, Prime Minister Narendra Modi, the Ministry of Culture, and the Ministry of Tourism in his post, the minister signalled that the push cuts across multiple arms of the Union government. The minister reaffirmed a collective commitment to 'making India a preferred global destination for healing and holistic wellness.'
Policy Backdrop
India's Medical Value Travel push has a layered policy lineage. Dedicated medical visas were introduced as far back as 2005 to ease entry for patients seeking treatment, yet procedural bottlenecks and insurance gaps have persisted as recurring complaints from private hospitals and international patient facilitators. The establishment of the Ministry of AYUSH in 2014 added a formal institutional home for integrating traditional systems — Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homeopathy — into the broader medical tourism framework.
The 'Heal in India' initiative, launched in 2022, was designed to stitch together these threads by coordinating promotion across ministries and private-sector hospitals under a single umbrella. The current inter-ministerial stakeholder meeting represents a continuation of that coordination effort, with renewed focus on the friction points that deter international patients from choosing India over competing destinations in Southeast Asia.
Stakeholders and Impact
The meeting drew participants from across the Medical Value Travel ecosystem — private hospital chains, AYUSH providers, and government departments whose mandates intersect with health tourism, including those overseeing visa policy, insurance regulation, and foreign exchange. India's competitive advantage in this space rests on a combination of significantly lower procedure costs compared with Western markets and a growing portfolio of wellness offerings anchored in traditional medicine. Successive governments have linked expansion of medical tourism to service export targets and foreign exchange inflows, making the sector strategically important beyond its direct healthcare value.
International patients travelling to India for treatment span a wide geography — from Africa, South Asia, and the Middle East — and the ability to offer seamless visa processing and cashless insurance settlement is considered critical to scaling volumes. Private hospitals have long flagged insurance interoperability and payment repatriation as pain points that erode India's price advantage.
What's Next
The immediate watch-points are any revised medical visa protocols or insurance framework changes that emerge from the deliberations, along with India's participation in upcoming global health tourism forums where the country's positioning will be tested against rival destinations. With the Ministry of Tourism and Ministry of AYUSH both in the room, the groundwork for a more coordinated promotional campaign — potentially building on the 'Heal in India' brand — appears to be taking shape. Whether the meeting translates into notified policy changes or remains at the level of inter-ministerial dialogue will determine its real-world impact on patient inflows and foreign exchange earnings.